|
Re: Gordon Research Conference Presentation Thursday June 14th
|
7
|
Resverlogix Corp.
|
Jun 12, 2018 12:40PM
|
|
Re: ... DSMB estimate is off...
|
5
|
Resverlogix Corp.
|
Jun 12, 2018 02:15PM
|
|
Re: Gordon Research Conference Presentation Thursday June 14th
|
5
|
Resverlogix Corp.
|
Jun 13, 2018 07:53PM
|
|
Re: Gordon Research Conference Presentation Thursday June 14th
|
3
|
Resverlogix Corp.
|
Jun 13, 2018 10:59PM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
6
|
Resverlogix Corp.
|
Jun 14, 2018 03:36PM
|
|
Alkaline Phosphatase and Alzheimer's Disease
|
8
|
Resverlogix Corp.
|
Jun 15, 2018 10:33AM
|
|
Re: Alkaline Phosphatase and Alzheimer's Disease
|
2
|
Resverlogix Corp.
|
Jun 15, 2018 01:10PM
|
|
Re: Can we infer perhaps that BETonMACE is properly powered from the FDA news?
|
6
|
Resverlogix Corp.
|
Jun 18, 2018 08:49AM
|
|
American Diabetes Association Meeting June 22-26, 2018
|
5
|
Resverlogix Corp.
|
Jun 18, 2018 11:02AM
|
|
Re: Great surge in PPS for fellow RVX investers
|
7
|
Zenith Epigenetics
|
Jun 19, 2018 11:26AM
|
|
AAIC presentation in July
|
4
|
Resverlogix Corp.
|
Jun 19, 2018 12:06PM
|
|
The significance of the SSRA
|
6
|
Resverlogix Corp.
|
Jun 19, 2018 01:03PM
|
|
An AHA or ASN Late Breaking Clinical Trial Presentation is possible
|
5
|
Resverlogix Corp.
|
Jun 19, 2018 01:21PM
|
|
Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 19, 2018 02:08PM
|
|
ESC 2018 Symposium
|
5
|
Resverlogix Corp.
|
Jun 19, 2018 03:11PM
|
|
Re: Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 19, 2018 09:51PM
|
|
Re: The significance of the SSRA
|
4
|
Resverlogix Corp.
|
Jun 20, 2018 10:20AM
|
|
Not even on the radar in this "state of the art" review
|
3
|
Resverlogix Corp.
|
Jun 20, 2018 11:52AM
|
|
Re: Not even on the radar in this "state of the art" review
|
6
|
Resverlogix Corp.
|
Jun 20, 2018 02:45PM
|
|
Re: Not even on the radar in this "state of the art" review
|
5
|
Resverlogix Corp.
|
Jun 20, 2018 03:07PM
|
